{
  "id": 6290582,
  "title": "Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers",
  "url": "https://urgent.news/2026/09/08/novartis-and-boston-scientific-slide-intel-price-hikes-stock-movers",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T14:23:49.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-09-08/novartis-dips-intel-gains-on-price-hikes-stock-movers-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "On this episode of Stock Movers: - Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}